Nahdi Medical Co. in the news

Nahdi Medical Co. established Rawa Alsihha Co. as a wholly owned subsidiary to enhance its supply chain, logistics, distribution, and delivery capabilities for future growth.

Nahdi Medical Company generated 10.21 billion SAR in revenue last year, with its Pharma segment being the primary contributor at 5.44 billion SAR, mainly from Saudi Arabia and UAE.

Nahdi Medical Company is going ex-dividend soon, but its high dividend payout from earnings and flat earnings growth raise concerns about its sustainability as a dividend stock.

Nahdi Medical Company's stock has a current price of 92.95 SAR, with analyst forecasts ranging from 100.00 to 142.00 SAR, and the company has a market capitalization of 12.09 billion SAR.

Nahdi Medical Co. shareholders approved quarterly or semi-annual dividend payouts for 2026 and set 2025 board compensation.

Nahdi Medical Co. grew its quarterly revenue to SAR 2.79 billion through digital sales and healthcare expansion despite a slight dip in net profit.

Nahdi Medical Company partnered with six charitable health associations to expand its "Convoys of Hope" program, aiming to improve healthcare access in remote areas across Saudi Arabia.

Nahdi Medical Co. employs 6,063 staff members and operates as a leading health retail gateway in the region.

Nahdi Medical Co. is projected to grow its global workforce to 5,172 employees by March 2026, a 2.5% increase from 2023.

Abdullah Amer Al Nahdi founded Nahdi Medical, Saudi Arabia's largest pharmacy chain, which went public in 2022 and has expanded into primary healthcare services.

Nahdi Medical Company's Q2 earnings met analyst expectations, with forecasts for accelerated revenue growth outpacing the industry.

Nahdi Medical Co. and NUPCO are launching the "Wasfaty" prescription dispensing service, available in Nahdi stores from October 2025.

Nahdi Medical reported over $1 billion in H1-2025 revenue and announced a SAR 338 million dividend payout despite a slight dip in Q2 quarterly profits.

Nahdi Medical, founded by Abdullah Amer Al Nahdi, is Saudi Arabia's largest pharmacy chain with over 1,181 locations and a recent expansion into primary healthcare services.

Nahdi Medical Co. grew its pharmacy network, boosted private-label sales, increased online revenue by 40%, and expanded its loyalty program in 2024.

Nahdi Medical Co.'s NahdiCare clinics segment exceeded its 2026 targets by opening its 10th clinic this year, experiencing 100% revenue growth, and planning further expansion.

Nahdi Medical Company partnered with the "Made in Saudi" program to promote Saudi-made health products and localize the pharmaceutical industry through dedicated pharmacy shelves and increased awareness.

Strategic distribution of locally manufactured medical products across 1,100 pharmacies to boost Saudi industrial growth and international expansion.

A new specialized NahdiCare clinic has opened in Najran City to provide comprehensive 24/7 medical services and advanced diagnostic technology.

Nahdi Medical Company's Solution Project, which uses AI and data to personalize customer experiences and recommendations, won the Store Retail Initiative of the Year at the Retail Asia Awards 2024.